Intravenous lysine clonixinate for the acute treatment of migraine: An open pilot study;Clonixinato de lisina injetavel intravenoso para o tratamento agudo das enxaquecas

Arquivos de Neuro-Psiquiatria

Volumn 57, Issue 3 A, 1999, Pages 606-609

  Krymchantowski, Abouch V ^a   Barbosa, Jackeline ^b  

^a CATDC RJ   (Brazil)

^b NONE

Author keywords

Acute treatment; Lysine clonixinate; Migraine

Indexed keywords

CLONIXIN LYSINE; ANALGESIC AGENT; CLONIXIN; DRUG DERIVATIVE; LYSINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG STRUCTURE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY COLIC; MALE; MIGRAINE; MYALGIA; NAUSEA; NERVE COMPRESSION; ORTHOSTATIC HYPOTENSION; PAIN ASSESSMENT; SOMNOLENCE; TOOTH PAIN; VERTIGO; VOMITING; ACUTE DISEASE; ADOLESCENT; AGED; MIDDLE AGED; PILOT STUDY; PROSPECTIVE STUDY;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANALGESICS; CLONIXIN; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; LYSINE; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PAIN MEASUREMENT; PILOT PROJECTS; PROSPECTIVE STUDIES;

EID: 0033182508     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x1999000400011     Document Type: Article

References (16)

1. Stewart WF, Shechter A, Lipton RB. Migraine heterogeneity, disability, pain intensity, and attack frequency and duration. Neurology 1994;44(Suppl 4):S24-S39
2. Rasmussen BK. Epidemiology of headache. Cephalalgia 1995;15:45-68.
3. Stewart WF, Lipton RB, Simon D. Work-related disability: results from the American migraine study. Cephalalgia 1996;16: 231-238.
4. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(Suppl. 7):1-96.
5. Silberstein SD. Preventive treatment of migraine: an overview. Cephalalgia 1997;17: 67-72.
6. Goadsby PJ, Edvinson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990;28:183-187.
7. Olesen J, Friberg L, Skyhoj-Olsen T. Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol 1990;28:791-798.
8. Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligoemia and impaired activation of rCBF in classic migraine. Ann Neurol 1981;9:344-352.
9. Saxena PR. Cranial arteriovenous shunting: an in vivo animal model for migraine. In Olesen J. Moskowitz MA (eds.) Experimental headache models. Philadelphia: Lippincott-Raven, 1995:119-122.
10. Tfelt-Hansen P, Lipton RB. Prioritizing treatment. In Olesen J, Tfelt-Hansen P, Welch KMA (eds.) The headaches. New York: Raven Press, 1993:359-362.
11. Lipton RB, Stewart WF, Ryan RE, Saper J, Silberstein S, Sheftell F. Efficacy and safety of the nonprescription combination of acetaminophen, aspirin, and caffeine in alleviating headache pain of an acute migraine attack: three double-blind, randomized, placebo-controlled trials. Arch Neurol 1998;55:210-217.
12. Mesquita CT. Clonixinato de lisina no tratamento de enxaquecas. Rev Bras Med 1996;53:1128-1131.
13. Pereyra Quintana JR, Levy DE Brocato N. Comparacion del efecto analgesico del clonixinato de lisina com un hipno-analgesico. El Día Médico 1978;50:6-23.
14. Taber RI, Lairanyi MB. Antagonism of the analgesic effect of opioid and non-opioid agents by p-chloro-phenylalanine (PCPA). Eur J Pharmacol 1981;75:215.
15. th Latinoamer Congr Pharmacol Therap. Santiago, 1982:64.
16. Paredes H. The use of intravenous lysine clonixinate for rapid pain relief: an open clinical study. Curr Therap Res 1996;40:86-91.